<DOC>
	<DOCNO>NCT02578914</DOCNO>
	<brief_summary>This randomize , parallel , single center , double mask , vehicle control study . The purpose study determine activity safety NS2 patient grass , tree ragweed-pollen induce seasonal allergic conjunctivitis . Subjects randomize 1:1 receive multiple dos NS2 Ophthalmic Drops ( 0.5 % ) NS2 Ophthalmic Drops Vehicle ( 0.0 % ) . Free aldehyde think related inflammatory condition allergic conjunctivitis . NS2 , small molecule aldehyde trap , evaluate determine whether may decrease inflammation lower aldehyde level .</brief_summary>
	<brief_title>A Safety Activity Study NS2 Subjects With Allergic Conjunctivitis</brief_title>
	<detailed_description />
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis , Allergic</mesh_term>
	<mesh_term>Rhinitis , Allergic , Seasonal</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Graded conjunctival redness least one region ( nasal temporal ) eye one time point ( necessarily time point ) postCAPT ( Conjunctival Allergen Provocation Test ) &gt; 2 Graded ocular itch one time point Visual acuity least 20/50 eye At least 2 year history moderate severe allergic conjunctivitis . Positive skin prick test ragweed , grass and/or tree pollen within one year Screening Visit ( Visit 1 ) . Ability avoid topical systemic ocular medication entire study period . Subjects must ocular itch score &gt; 0 conjunctival redness score &gt; 1 prior CAPT either eye region ( nasal temporal ) Visits 24 . I History glaucoma , Intraocular Pressure ( IOP ) 25mmHg screen visit , history elevate IOP within past 1 year . Ocular surgery , include laser procedure , within past 12 month Visit 1 . Use glaucoma medication , antibiotic , antiviral , topical cyclosporine within 1 month screen visit . History dry eye syndrome , blepharitis , herpes simplex keratitis herpes zoster keratitis . History uveitis past 3 year . Presence ocular infection active ocular inflammation ( e.g . follicular conjunctivitis , allergic conjunctivitis ) within 14 day prior start study ( Visit 1 ) . History moderate severe asthma allergy induce asthma allergen use CAPT . Use oral corticosteroid within 30 day screen throughout study period ; use intranasal inhale corticosteroid within 14 day screen throughout study period . Use antihistamine ( ocular , nasal , topical oral ) within 7 day prior screen ( Visit 1 ) throughout study period . Nonmedicated artificial tear allow 72 hour screen ( Visit 1 ) throughout study period .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>allergic conjunctivitis</keyword>
	<keyword>seasonal allergy</keyword>
	<keyword>ragweed allergy</keyword>
	<keyword>grass allergy</keyword>
	<keyword>tree allergy</keyword>
	<keyword>NS2</keyword>
	<keyword>Aldeyra</keyword>
</DOC>